Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a ...

The US Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient’s memory problems are likely caused by Alzheimer’s disease.

The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...

Tests like electrocardiograms or a blood test for cholesterol offer good measures of heart health. But the American College ...

Investigators employed the Accelerating Medicines Partnership to identify noninvasive biomarkers of lupus nephritis pathology and treatment response.

In Canada, pancreatic cancer is “an underfunded area of cancer research,” according to the Terry Fox Research Institute. The aggressive disease is rapidly on the rise, “and by 2030 pancreatic cancer ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...